Ironwood Pharmaceuticals (IRWD) Income from Discontinued Operations (2010 - 2019)
Ironwood Pharmaceuticals' (IRWD) quarterly Income from Discontinued Operations came in at -$37.4 million in Q1 2019, down 125.73% year-over-year from $145.5 million in Q1 2018, and down 56.87% quarter-over-quarter from -$23.9 million in Q4 2018.
Analysis
Ironwood Pharmaceuticals (IRWD) Income from Discontinued Operations (2010 - 2019) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Income from Discontinued Operations across 3 years of filings, most recently posting -$37.4 million for Q1 2019.
- In Q1 2019, Income from Discontinued Operations fell 125.73% year-over-year to -$37.4 million; the TTM figure through Dec 2019 stood at -$37.4 million (up 57.56% YoY), while the FY2019 annual figure was -$37.4 million, up 57.56% from the prior year.
- Income from Discontinued Operations came in at -$37.4 million for Q1 2019 at Ironwood Pharmaceuticals, down from -$23.9 million in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of -$16.6 million in Q1 2018 to a low of -$37.4 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.56 Bn | 197.57 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.34 Bn | 178.16 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.55 Bn | 56.37 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.32 Bn | 49.19 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.32 Bn | 31.01 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.24 Bn | 29.95 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.17 Bn | 30.17 Bn | 1.16 Mn | - |
| 10 | Ironwood Pharmaceuticals | 671.59 Mn | 592.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -37.44 Mn |
| Dec 31, 2018 | -23.87 Mn |
| Sep 30, 2018 | -22.53 Mn |
| Jun 30, 2018 | -25.24 Mn |
| Mar 31, 2018 | -16.59 Mn |
| Sep 30, 2010 | 6.37 Mn |
| Jun 30, 2010 | -44,000.00 |